Yes, it's time for another Steam sale. This one might have snuck up on you, between current events, March Madness, and three major releases that have their claws in tight on the gaming populace. But ...
SRPT plans FDA filings to convert Amondys 45 and Vyondys 53 to full approvals, leveraging new data despite a missed endpoint in its confirmatory study.
Management flagged that 2025 investment cycles in headcount will lead to higher year-over-year OpEx growth in early 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results